Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): Relation to lymphocyte activation and disease activity

Lupus

Volumn 10, Issue 12, 2001, Pages 866-872

  Bijl, M ^a   Horst, G ^a   Limburg, P C ^a   Kallenberg, C G M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Apoptosis; CD95; Fas; Lymphocyte activation; SLE

Indexed keywords

CD19 ANTIGEN; CD38 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; FAS ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 2 RECEPTOR;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE PREDISPOSITION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MALE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ADULT; AGED; ANTIGENS, CD19; ANTIGENS, CD95; APOPTOSIS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 0035666988     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120301701548517     Document Type: Article

References (29)

1. Apoptosis in systemic lupus erythematosus. Clinical implications
2. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
3. Systemic exposure to irradiated apoptotic cells induces autoantibody production
4. High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus
5. Lymphocyte apoptosis in systemic lupus erythematosus: Relationships with Fas expression, serum soluble Fas and disease activity
6. A possible role of apoptosis for regulating autoreactive responses in systemic lupus erythematosus
7. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus
8. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases
9. Anti-dsDNA production coincides with concurrent B and T cell activation during development of active disease in systemic lupus erythematosus (SLE)
10. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
11. Monoclonal antibody-mediated tumor regression by induction of apoptosis
12. The Fas death factor
13. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
14. The apoptosis-1/Fas protein in human systemic lupus erythematosus
15. Anti-CD3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus (SLE)
16. The 1982 revised criteria for the classification of systemic lupus erythematosus
17. Derivation of the SLEDAI. A disease activity index for lupus patients
18. Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study
19. Inhibition of Fas/Fas ligand-mediated apoptotic cell death of lymphocytes in vitro by circulating anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus
20. Inhibition of caspase-3-mediated poly (ADP-ribose) polymerase (PARP) apoptotic cleavage by human PARP autoantibodies and effect on cells undergoing apoptosis
21. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
22. Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases
23. Apoptosis and expression of soluble Fas mRNA in systemic lupus erythematosus
24. Patients with systemic lupus erythematosus with high plasma levels of sFas risk relapse
25. Apoptosis in the pathogenesis and treatment of disease
26. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity
27. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: Relations with disease activity, antibodies to double stranded DNA, and neutropenia
28. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes
29. Up-regulated expression of Fas antigen (CD95) by peripheral naive and memory T cell subsets in patients with systemic lupus erythematosus (SLE): A possible mechanism for lymphopenia